Drug Shortage Report for TWYNSTA

Last updated on 2020-09-19 History
Report ID 123133
Drug Identification Number 02371057
Brand name TWYNSTA
Common or Proper name Twynsta
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status MARKETED
Active Ingredient(s) TELMISARTAN AMLODIPINE
Strength(s) 80MG 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 28's
ATC code C09DB
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-08-31
Actual start date 2020-09-11
Estimated end date 2020-09-28
Actual end date 2020-09-18
Shortage status Resolved
Updated date 2020-09-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-09-19 English Compare
v5 2020-09-18 French Compare
v4 2020-09-18 English Compare
v3 2020-09-01 English Compare
v2 2020-08-28 French Compare
v1 2020-08-28 English Compare

Showing 1 to 6 of 6